HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life

Autor:	V. Cento, S. Barbaliscia, I. Lenci, T. Ruggiero, C. Masetti, C.F. Magni, V. Micheli, S. Paolucci, Y. Troshina, E. Biliotti, M. Milana, M. Melis, E. Teti, L. Lambiase, B. Menzaghi, L.A. Nicolini, S. Marenco, V.C. Di Maio, M. Aragri, A. Pecchioli, A. Bertoli, F.P. Antonucci, L. Sarmati, C. Sarrecchia, M. Macera, N. Coppola, E. Danieli, D. Romagnoli, A. Pellicelli, S. Bonora, S. Babudieri, A. Di Biagio, A. Picciotto, S. Novati, M. Siciliano, V. Messina, E. Claar, F. Baldanti, C. Pasquazzi, A. Ciancio, M. Puoti, V. Ghisetti, M. Andreoni, G. Taliani, G. Rizzardini, M. Angelico, C.F. Perno, F. Ceccherini-Silberstein
Rok vydání:	2017
Předmět:	Resistance test Protease Hepatology business.industry medicine.medical_treatment Gastroenterology medicine In real life Pharmacology business
Zdroj:	Digestive and Liver Disease. 49:e53
ISSN:	1590-8658
DOI:	10.1016/j.dld.2017.01.107
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7162804d7860bd6c340b0b8a2840610b https://doi.org/10.1016/j.dld.2017.01.107 Zobrazit plný text záznamu Full Text from ScienceDirect